2010
DOI: 10.3109/08941930903564100
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the Osteogenic Performance of Calcium Phosphate-Chitosan Bone Fillers

Abstract: There has been recent interest in utilizing calcium phosphates (CaPs) that set in situ for treating bone defects due to the limitations associated with morselized autografts and allografts. However, CaP cements have long setting times, poor mechanical properties, and poor osteoinductivity. This has prompted research toward finding a nonprotein-based compound, such as chitosan, to accelerate setting times and increase osteoinductivity. The purpose of this study was to compare bone growth rates during the early … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 26 publications
0
6
0
Order By: Relevance
“…Instead of using bone cement as a void filler in elderly patients with osteoporotic bone, calcium phosphate (CaP)-chitosan formulations might be applied to the bony defect as a void filler as these formulations were previously identified to stimulate initial bone formation [29]; in addition, in a senescence-accelerated osteoporotic mouse model (SAMP6) delayed fracture healing was noted to occur in advanced age SAMP6 mice [30].…”
Section: Discussionmentioning
confidence: 99%
“…Instead of using bone cement as a void filler in elderly patients with osteoporotic bone, calcium phosphate (CaP)-chitosan formulations might be applied to the bony defect as a void filler as these formulations were previously identified to stimulate initial bone formation [29]; in addition, in a senescence-accelerated osteoporotic mouse model (SAMP6) delayed fracture healing was noted to occur in advanced age SAMP6 mice [30].…”
Section: Discussionmentioning
confidence: 99%
“…Incorporation of chitosan in bone cement has the potential to stimulate bone formation (18,39,48) and prevent bacterial colonization and biofilm formation on the bone cement surface (43). With its improved antimicrobial activity, HACC represents an attractive option for the impregnation of bone cement to provide a promising new strategy for combating orthopedic implant infections.…”
Section: Vol 55 2011 Quaternized Chitosan Inhibits Biofilm Formatiomentioning
confidence: 99%
“…Chitosan activates macrophages and mononuclear cells and induces the production of various growth factors (20). In addition, it has received recent attention as an effective carrier system for the release of bioactive agents, particularly bone morphogenetic proteins, to enhance bone formation in vitro and in vivo (21,22). This has potential as a novel therapeutic mechanism as it is believed that mesenchymal cells are able to differentiate into osteoblasts when stimulated by local factors such as bone morphogenetic proteins and lead to bone regeneration (23).…”
Section: Discussionmentioning
confidence: 99%